Cargando…

Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients

The purpose was to evaluate the potential of diffusion-weighted-magnetic resonance imaging (DW-MRI) and (18)F-fludeoxy-glucose-positron emission tomography integrated with CT (FDG-PET/CT) for prediction of overall survival (OS) following AdCD40L-immunotherapy in patients with metastatic malignant me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schiza, Aglaia, Irenaeus, Sandra, Ortiz-Nieto, Francisco, Loskog, Angelica, Tötterman, Thomas, Sundin, Anders, Ullenhag, Gustav J., Ahlström, Håkan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889008/ https://www.ncbi.nlm.nih.gov/pubmed/31792256 http://dx.doi.org/10.1038/s41598-019-54438-x

Ejemplares similares

Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients
por: Irenaeus, Sandra, et al.
Publicado: (2017)

Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients
por: Loskog, Angelica, et al.
Publicado: (2016)

Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients
por: Schiza, A., et al.
Publicado: (2017)

Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancer
por: Eriksson, Emma, et al.
Publicado: (2016)

Whole-body MRI including diffusion-weighted imaging compared to CT for staging of malignant melanoma
por: Mosavi, Firas, et al.
Publicado: (2013)

Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy
por: Sjöholm, Therese, et al.
Publicado: (2022)

Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models
por: Wenthe, Jessica, et al.
Publicado: (2023)

Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy
por: Sjöholm, Therese, et al.
Publicado: (2023)

Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas–Long-Term Follow Up
por: Saellstrom, Sara, et al.
Publicado: (2021)

Colonic Malignant Melanoma: (18)F-FDG PET/CT Findings
por: Kaya, Eser, et al.
Publicado: (2018)

Quantitative comparison of data-driven gating and external hardware gating for (18)F-FDG PET-MRI in patients with esophageal tumors
por: Kvernby, Sofia, et al.
Publicado: (2021)

On the Added Value of Baseline FDG-PET in Malignant Lymphoma
por: Quarles van Ufford, Henriette, et al.
Publicado: (2009)

Baker’s Cyst on F-18 FDG PET/CT in a Patient with Ocular Melanoma
por: Cayvarlı, Hakan, et al.
Publicado: (2012)

Immune priming using DC- and T cell-targeting gene therapy sensitizes both treated and distant B16 tumors to checkpoint inhibition
por: Wenthe, Jessica, et al.
Publicado: (2022)

A whole-body FDG PET/MR atlas for multiparametric voxel-based analysis
por: Sjöholm, Therese, et al.
Publicado: (2019)

The potential added value of FDG PET/CT for COVID-19 pneumonia
por: Deng, Yan, et al.
Publicado: (2020)

FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD
por: Kantarci, Kejal, et al.
Publicado: (2021)

Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo
por: Sandin, Linda C, et al.
Publicado: (2014)

Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma
por: Tholander, Bengt, et al.
Publicado: (2020)

(18)F-FDG PET-CT for Staging of Conjunctival Melanoma
por: Damian, Andres, et al.
Publicado: (2013)

Diagnostic utility of ASL‐MRI and FDG‐PET in the behavioral variant of FTD and AD
por: Tosun, Duygu, et al.
Publicado: (2016)

Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment
por: Eriksson, E, et al.
Publicado: (2017)

Estimating the cold-induced brown adipose tissue glucose uptake rate measured by (18)F-FDG PET using infrared thermography and water-fat separated MRI
por: Andersson, Jonathan, et al.
Publicado: (2019)

Simultaneous FDG-PET/MRI detects hippocampal subfield metabolic differences in AD/MCI
por: Carlson, Mackenzie L., et al.
Publicado: (2020)

The Added Value of [(18)F]FDG PET/CT in the Management of Invasive Fungal Infections
por: Ankrah, Alfred O., et al.
Publicado: (2021)

Cancer treatment of today in view of the Nobel Prize
por: Ullenhag, Gustav
Publicado: (2018)

Validation of (18)F-FDG PET/MRI and diffusion-weighted MRI for estimating the extent of peritoneal carcinomatosis in ovarian and endometrial cancer -a pilot study
por: Jónsdóttir, Björg, et al.
Publicado: (2021)

Added value of regional (18)F-FDG PET/MRI-assisted whole-body (18)F-FDG PET/CT in malignant ascites with unknown primary origin
por: Fu, Yiru, et al.
Publicado: (2023)

Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay
por: Blokzijl, Andries, et al.
Publicado: (2016)

Reply to: The diagnostic accuracy of (18)F-FDG PET in cutaneous malignant melanoma
por: Delgado-Bolton, Roberto C., et al.
Publicado: (2010)

Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients
por: Kudura, Ken, et al.
Publicado: (2021)

[(18)F]FDG PET/CT in the Evaluation of Melanoma Patients Treated with Immunotherapy
por: Mangas Losada, María, et al.
Publicado: (2023)

Cardiac Metastasis of Malignant Melanoma Detected by (18)F-FDG PET/CT
por: Zhang, Hongzhe, et al.
Publicado: (2023)

Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40
por: Wenthe, Jessica, et al.
Publicado: (2020)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

PET-FDG: Impetus
por: Nanni, Cristina
Publicado: (2020)

Preoperative FDG-PET/CT Is an Important Tool in the Management of Patients with Thick (T4) Melanoma
por: Arrangoiz, Rodrigo, et al.
Publicado: (2012)

Ruptured epidermal cyst mimicking cutaneous melanoma on F-18 FDG PET/CT
por: Nguyen, Ba D., et al.
Publicado: (2015)

Comparison of (18)F-FDG PET/CT and ultrasound in staging of patients with malignant melanoma
por: Weber, Philipp, et al.
Publicado: (2022)

Kick-starting the cancer-immunity cycle by targeting CD40
por: Ellmark, P, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ooa47kae1vfjb72616k010858s